Liver disease accompanied by enteropathy in common variable immunodeficiency: Common pathophysiological mechanisms

Imagem de Miniatura
Arquivos
art_LIMA_Liver_disease_accompanied_by_enteropathy_in_common_variable_2022.PDF (6.41 MB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
Citação
FRONTIERS IN IMMUNOLOGY, v.13, article ID 933463, 19p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Common variable immunodeficiency (CVID) is one of the inborn errors of immunity that have the greatest clinical impact. Rates of morbidity and mortality are higher in patients with CVID who develop liver disease than in those who do not. The main liver disorder in CVID is nodular regenerative hyperplasia (NRH), the cause of which remains unclear and for which there is as yet no treatment. The etiology of liver disease in CVID is determined by analyzing the liver injury and the associated conditions. The objective of this study was to compare CVID patients with and without liver-spleen axis abnormalities in terms of clinical characteristics, as well as to analyze liver and duodenal biopsies from those with portal hypertension (PH), to elucidate the pathophysiology of liver injury. Patients were divided into three groups: Those with liver disease/PH, those with isolated splenomegaly, and those without liver-spleen axis abnormalities. Clinical and biochemical data were collected. Among 141 CVID patients, 46 (32.6%) had liver disease/PH; 27 (19.1%) had isolated splenomegaly; and 68 (48.2%) had no liver-spleen axis abnormalities. Among the liver disease/PH group, patients, even those with mild or no biochemical changes, had clinical manifestations of PH, mainly splenomegaly, thrombocytopenia, and esophageal varices. Duodenal celiac pattern was found to correlate with PH (p < 0.001). We identified NRH in the livers of all patients with PH (n = 11). Lymphocytic infiltration into the duodenal mucosa also correlated with PH. Electron microscopy of liver biopsy specimens showed varying degrees of lymphocytic infiltration and hepatocyte degeneration, which is a probable mechanism of lymphocyte-mediated cytotoxicity against hepatocytes and enterocytes. In comparison with the CVID patients without PH, those with PH were more likely to have lymphadenopathy (p < 0.001), elevated beta(2)-microglobulin (p < 0.001), low B-lymphocyte counts (p < 0.05), and low natural killer-lymphocyte counts (p < 0.05). In CVID patients, liver disease/PH is common and regular imaging follow-up is necessary. These patients have a distinct immunological phenotype that may predispose to liver and duodenal injury from lymphocyte-mediated cytotoxicity. Further studies could elucidate the cause of this immune-mediated mechanism and its treatment options.
Palavras-chave
inborn errors of immunity (IEI), primary immunodeficiency (PID), common variable immunodeficiency (CVID), portal hypertension, liver disease, nodular regenerative hyperplasia (NRH), enteropathy, duodenal celiac pattern
URI
https://observatorio.fm.usp.br/handle/OPI/50686
Referências
  1. Abbott JK, 2015, IMMUNOL ALLERGY CLIN, V35, P637, DOI 10.1016/j.iac.2015.07.009
  2. Abolhassani H, 2020, BLOOD, V135, P656, DOI 10.1182/blood.2019000929
  3. Aggarwal V, 2020, GENES DIS, V7, P26, DOI 10.1016/j.gendis.2019.10.002
  4. Al-Mukhaizeem KA, 2004, AM J HEMATOL, V75, P225, DOI 10.1002/ajh.20024
  5. Ameratunga R, 2020, IMMUNOL ALLERGY CLIN, V40, P403, DOI 10.1016/j.iac.2020.03.001
  6. Atalaia-Martins C, 2017, ACG CASE REP J, V4, DOI 10.14309/crj.2017.106
  7. Austin A, 2004, GUT, V53, P1032, DOI 10.1136/gut.2003.036806
  8. Azzu V, 2019, J ALLER CL IMM-PRACT, V7, P2484, DOI 10.1016/j.jaip.2019.04.016
  9. Baldassim MPM., 2014, THESIS FAC MED U SAO
  10. Bates CA, 2004, J ALLERGY CLIN IMMUN, V114, P415, DOI 10.1016/j.jaci.2004.05.057
  11. Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
  12. Biagi F, 2012, AM J CLIN PATHOL, V138, P185, DOI 10.1309/AJCPEIILH2C0WFYE
  13. BJERRUM OW, 1990, SCAND J IMMUNOL, V32, P233, DOI 10.1111/j.1365-3083.1990.tb02916.x
  14. Boileau J, 2011, J AUTOIMMUN, V36, P25, DOI 10.1016/j.jaut.2010.10.002
  15. Bonilla FA, 2016, J ALLER CL IMM-PRACT, V4, P38, DOI 10.1016/j.jaip.2015.07.025
  16. Brown LAK, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1926
  17. Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545
  18. Chawla Y, 2008, SEMIN LIVER DIS, V28, P270, DOI 10.1055/s-0028-1085095
  19. Chiou SJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126330
  20. Crescenzi L, 2019, DIGEST LIVER DIS, V51, P1599, DOI 10.1016/j.dld.2019.05.016
  21. Crotty R, 2020, AM J SURG PATHOL, V44, P617, DOI 10.1097/PAS.0000000000001452
  22. Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725
  23. Daniels JA, 2007, AM J SURG PATHOL, V31, P1800, DOI 10.1097/PAS.0b013e3180cab60c
  24. Daniels JA, 2009, HUM PATHOL, V40, P484, DOI 10.1016/j.humpath.2008.09.008
  25. Fuss IJ, 2013, J CLIN IMMUNOL, V33, P748, DOI 10.1007/s10875-013-9873-6
  26. Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077
  27. Goel A, 2013, INDIAN J MED RES, V137, P922
  28. Hartleb M, 2011, WORLD J GASTROENTERO, V17, P1400, DOI 10.3748/wjg.v17.i11.1400
  29. Islek A, 2021, ACTA GASTRO-ENT BELG, V84, P305, DOI 10.51821/84.2.305
  30. Jolles S, 2013, J ALLER CL IMM-PRACT, V1, P545, DOI 10.1016/j.jaip.2013.09.015
  31. Kaukinen K, 2002, GASTROENTEROLOGY, V122, P881, DOI 10.1053/gast.2002.32416
  32. Khodadad A, 2007, DIGEST DIS SCI, V52, P2977, DOI 10.1007/s10620-006-9736-6
  33. Kingham JGC, 1998, GUT, V42, P120, DOI 10.1136/gut.42.1.120
  34. Machado Márcio Martins, 2004, Radiol Bras, V37, P35, DOI 10.1590/S0100-39842004000100009
  35. Malamut G, 2008, J HEPATOL, V48, P74, DOI 10.1016/j.jhep.2007.08.011
  36. Malamut G, 2010, AM J GASTROENTEROL, V105, P2262, DOI 10.1038/ajg.2010.214
  37. Mannon PJ, 2006, GASTROENTEROLOGY, V131, P748, DOI 10.1053/j.gastro.2006.06.022
  38. Matsumoto T, 2000, LIVER, V20, P366, DOI 10.1034/j.1600-0676.2000.020005366.x
  39. Mayor PC, 2018, J ALLERGY CLIN IMMUN, V141, P1028, DOI 10.1016/j.jaci.2017.05.024
  40. Mechanic LJ, 1997, ANN INTERN MED, V127, P613, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00005
  41. Mieli-Vergani G, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.18, 10.1038/nrdp.2018.17]
  42. Mirzaagha F, 2010, DIGEST LIVER DIS, V42, P620, DOI 10.1016/j.dld.2010.02.006
  43. Morris JM, 2010, EUR J GASTROEN HEPAT, V22, P1001, DOI 10.1097/MEG.0b013e3283360021
  44. Myneedu K, 2021, ACG CASE REP J, V8, DOI 10.14309/crj.0000000000000547
  45. NABER AHJ, 1991, J HEPATOL, V12, P94, DOI 10.1016/0168-8278(91)90916-Y
  46. NORTH ME, 1991, CLIN EXP IMMUNOL, V86, P252
  47. Okabayashi A., 1983, IDIOPATHIC PORTAL HY, P197
  48. Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669
  49. Paquin-Proulx D, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004304
  50. Pecoraro A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00338
  51. Pecoraro A, 2018, J CLIN IMMUNOL, V38, P67, DOI 10.1007/s10875-017-0461-z
  52. Pikkarainen S, 2019, AM J GASTROENTEROL, V114, P648, DOI 10.14309/ajg.0000000000000140
  53. Pollock G, 2020, ACG CASE REP J, V7, DOI 10.14309/crj.0000000000000467
  54. Pulvirenti F, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/672458
  55. Reshamwala PA, 2006, HEPATOLOGY, V44, P7, DOI 10.1002/hep.21258
  56. Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945
  57. Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14
  58. Sarin SK, 1998, DIGESTION, V59, P420, DOI 10.1159/000007502
  59. Schouten JNL, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0288-8
  60. Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422
  61. Seve P, 2008, MEDICINE, V87, P177, DOI 10.1097/MD.0b013e31817a90ba
  62. Sharma BC, 2006, J GASTROEN HEPATOL, V21, P332, DOI 10.1111/j.1440-1746.2006.03296.x
  63. Shimamatsu K, 1997, HEPATOLOGY, V26, P343, DOI 10.1002/hep.510260214
  64. Sood A, 2014, WORLD J HEPATOL, V6, P55, DOI 10.4254/wjh.v6.i1.55
  65. Szablewski V, 2015, VIRCHOWS ARCH, V467, P733, DOI 10.1007/s00428-015-1862-0
  66. van Schewick CM, 2022, J CLIN IMMUNOL, V42, P46, DOI 10.1007/s10875-021-01104-5
  67. WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512
  68. Ward C, 2008, CLIN EXP IMMUNOL, V153, P331, DOI 10.1111/j.1365-2249.2008.03711.x
  69. Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544
  70. Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744
  71. Woodward J, 2017, CLIN EXP IMMUNOL, V188, P363, DOI 10.1111/cei.12884
  72. Woodward JM, 2015, AM J GASTROENTEROL, V110, P320, DOI 10.1038/ajg.2014.432
  73. Yeh MM, 2006, AM J SURG PATHOL, V30, P727, DOI 10.1097/00000478-200606000-00008
  74. Yilmaz B, 2014, WORLD J GASTROENTERO, V20, P10916, DOI 10.3748/wjg.v20.i31.10916
  75. Ziol M, 2004, HUM PATHOL, V35, P1241, DOI 10.1016/j.humpath.2004.06.016

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/06
Artigos e Materiais de Revistas Científicas - LIM/14
Artigos e Materiais de Revistas Científicas - LIM/19
Carregar mais